Open AccessPreserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies
Author(s) -
Brigid S. Boland,
Benjamin Goodwin,
Zeli Zhang,
Nathaniel I. Bloom,
Yu Kato,
Jennifer Neill,
Helen Le,
Tiffani Tysl,
Angelina Collins,
Parambir S. Dulai,
Siddharth Singh,
Nghia Nguyen,
Alba Grifoni,
Alessandro Sette,
Daniela Weiskopf,
John T. Chang,
Jennifer M. Dan
Publication year - 2022
Publication title -
clinical and translational gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.673
H-Index - 35
ISSN - 2155-384X
DOI - 10.14309/ctg.0000000000000484
Subject(s) - medicine , immunogenicity , immunology , infliximab , immune system , inflammatory bowel disease , vaccination , immunity , ulcerative colitis , vedolizumab , humoral immunity , disease , tumor necrosis factor alpha